CPHI Webinar Series
Unlocking Opportunities in the Growing Pharma Landscape of The Middle East
What will this webinar address?
CPHI Middle East, set to launch in Riyadh, Saudi Arabia from December 10-12, 2024, is a brand-new event for the region, offering a unique platform designed to foster cross-industry collaboration and to catalyze growth. The Middle East is the fifth largest pharma market globally, valued at USD 20 Billion, led by Saudi Arabia with a 37% market share.
A market poised for maturity; the Kingdom of Saudi has outlined an ambitious plan to revolutionize the life sciences industry - Vision 2030. The plan seeks to reduce reliance on imported medicines by building out a dynamic infrastructure of regional manufacturing facilities for both small and large molecule production.
This webinar will bring together key stakeholders to discuss the future of the Middle East pharma market. Discussion points include:
- Building out an eco-system to support localised manufacturing through partnerships, investment and tech-transfer
- How technology advancements from CPO’s can help accelerate production, reduce costs and mitigate risk.
- Establishing the region as an innovator market, how to incentivize and enable R&D to create a pipeline of home-grown innovative therapies.
- Identifying the opportunities for international pharma companies – why the Middle East presents a big opportunity for Big Pharma
Since assuming the role of CEO at YallaRx in 2019, Dr. Vatutina has steered the company to become a leading business service in the GCC market, focusing on the launch and sales of pharmaceutical and healthcare products. YallaRx is renowned for its extensive databases and market insights, providing clients with detailed analytical, regulatory, and marketing services designed specifically for the pharmaceutical and healthcare industry.
Dr. Manel Chikh is the founder and CEO of Zaphyr Pharmaceuticals, a pharma company that commercialize specialty products in the MEA region. Founded in 2012, Zaphyr focuses on oncology and rare diseases and operates between Switzerland, Ireland and Dubai.
Lucy Chard is the Digital Editor, Pharma at Informa Markets for the CPHI events portfolio. She has over 5 years of experience in science communications and publishing, in topics ranging from human medicine to the pharmaceutical supply chain, with a particular interest in sustainability and emerging markets.
-
5th June, 2024
-
15:00 CET / 9:00 EST
-
60 minutes
-
Free
Get the latest from CPHI in your inbox every week.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance